Contract Pharma

Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments

Recro, Ensysce Expand Development and Manufacturing Partnership

Additional contract broadens and further strengthens customer product portfolio.

Tim Wright, Editor, Contract Pharma 04.15.21

Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News

Alkermes, Merck Enter Clinical Trial and Supply Agreement

To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.

Tim Wright, Editor, Contract Pharma 04.07.21

Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.

Tim Wright, Editor, Contract Pharma 04.07.21

Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News

Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate

Work together to develop and commercialize CHI’s novel dry-powder inhaler product.

Charles Sternberg, Assistant Editor 04.07.21

Breaking News | Collaborations & Alliances | Industry News

CordenPharma Enters Alliance with Nanos of South Korea

Partnership represents Nanos’ intention to establish long-term production and sale of therapeutic drugs involving peptides.

Tim Wright, Editor, Contract Pharma 04.05.21

Aseptic Processing | Breaking News | Collaborations & Alliances | Industry News

Steriline Delivers New Manufacturing Line to Bess Pro

Provided a turnkey line, fully operating and ready to perform at full capacity.

Charles Sternberg, Assistant Editor 03.31.21

GSK Supports Manufacture of Novavax’ COVID-19 Vaccine

GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.

Tim Wright, Editor, Contract Pharma 03.31.21

Jubilant, Novavax Enter COVID-19 Vaccine Partnership

Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.

Tim Wright, Editor, Contract Pharma 03.29.21

mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity

Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.

Tim Wright, Editor, Contract Pharma 03.25.21

CyanVac and Exothera Enter COVID-19 Vaccine Partnership

CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.

Tim Wright, Editor, Contract Pharma 03.25.21

Breaking News | cGMP Manufacture | Collaborations & Alliances

BioCentriq, Kytopen Enter Cell Therapy Alliance

Demonstrates the impact of transformative technology on cell therapy manufacturing.

Charles Sternberg, Assistant Editor 03.24.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioCentriq and Kytopen Enter Cell Therapy Partnership

To show the impact to autologous and allogeneic cell therapies by integrating novel transfection technology with other steps in the manufacturing process.

Tim Wright, Editor, Contract Pharma 03.23.21

Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer

Plus Therapeutics, Piramal Ink Master Services Agreement

Development, manufacturing and supply deal is for Plus’ Rhenium NanoLiposome intermediate drug product.

Tim Wright, Editor, Contract Pharma 03.23.21

Breaking News | Collaborations & Alliances

Thermo Fischer Scientific Collaborates with Protein Metrics

Will facilitate precise, reliable mass spectrometry data processing and drive innovation for biopharmaceutical and proteomics applications.

Charles Sternberg, Assistant Editor 03.22.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec, Takeda Enter Multi-RNA Target Alliance

To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.

Kristin Brooks 03.22.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

RDIF & Stelis Enter Covid-19 Vaccine Supply Deal

Partner to supply 200 million doses of the Sputnik V vaccine.

Tim Wright, Editor, Contract Pharma 03.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Catalent Expands Partnership with J&J

To significantly increase capacity for sterile manufacturing and packaging of COVID-19 vaccine in Italy.

Tim Wright, Editor, Contract Pharma 03.17.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership

Enter license agreement for the development of iPSC-derived cell therapies.

Tim Wright, Editor, Contract Pharma 03.17.21

WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China

Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.

Tim Wright, Editor, Contract Pharma 03.17.21

Breaking News | Collaborations & Alliances | Industry News | Parenterals | Solid Dosage/Creams/Ointments

Gilead and Merck Ink HIV Agreement

Collaboration to focus on oral and injectable formulations of lenacapavir and islatravir.

Tim Wright, Editor, Contract Pharma 03.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine

Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 03.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Maravai Expands CDMO Capabilities Through TriLink Biotechnologies

Offers end-to-end mRNA production with the launch of TriLink's plasmid DNA manufacturing services.

Tim Wright, Editor, Contract Pharma 03.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioVaxys, Wuxi Biologics Enter Bioproduction Agreement

To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.

Tim Wright, Editor, Contract Pharma 03.15.21

Clinical Trials | Information Technology

The Evolution of Clinical Research Technology to Support Remote Collaboration

Pioneering change with technology advancements that yield high reward with tolerable risk.

Angela Gill Nelms, COO for Florence Healthcare 03.11.21

PhaseBio and BioVectra Enter into Supply Agreement

To support development and commercialization of bentracimab.

Tim Wright 03.11.21

Breaking News | Collaborations & Alliances | Drug Development

Selexis SA and BITT Enter Service Agreement

Will develop the cell line for BITR2101, BITT’s lead tumor necrosis factor receptor 2 oncology candidate.

Charles Sternberg, Assistant Editor 03.10.21

Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News

Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact

COVID-19 therapy Bamlanivimab will be manufactured at Jubilant HollisterStier's Spokane, WA facility.

03.09.21

Breaking News | Collaborations & Alliances | Industry News

Cassava Sciences Enters Drug Supply Agreement with Evonik

Evonik will supply Cassava Sciences with large-scale, clinical-grade quantities of simufilam.

Charles Sternberg, Assistant Editor 03.09.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

High Purity New England & Univercells Technologies Unveil Bioprocessing Solutions

New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.

Tim Wright, Editor, Contract Pharma 03.09.21

Baxter Biopharma Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine

Manufacturing to take place at Baxter’s state-of-the-art Halle/Westfalen, Germany facility.

Tim Wright, Editor, Contract Pharma 03.09.21

Breaking News | Collaborations & Alliances

Iontas and Fair Journey Biologics Partner with Quell Therapeutics

Novel target binders from Iontas/FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline.

Charles Sternberg, Assistant Editor 03.08.21

Breaking News | Collaborations & Alliances | Drug Delivery | Industry News

Aptamer Extends Collaboration with AstraZeneca

Will continue to explore next-generation drug delivery approaches.

Tim Wright, Editor, Contract Pharma 03.05.21

Innoforce and dMed Enter Development Collaboration

Aims to accelerate the development of innovative therapeutics.

Tim Wright, Editor, Contract Pharma 03.03.21

Breaking News | Collaborations & Alliances | Industry News

Phlow Corp. and USP Form Alliance

Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.

Tim Wright, Editor, Contract Pharma 03.01.21

Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology

Ashfield Engage, Popit Form Digital Monitoring Collaboration

Partner to improve patient adherence through supplemental real-time personalized support.

Tim Wright, Editor, Contract Pharma 02.26.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 02.25.21

Breaking News | Collaborations & Alliances | Drug Development | Industry News | Solid Dosage/Creams/Ointments

Pfizer Partners with Medicines Manufacturing Innovation Center

To transform the formulation of oral solid dosage medicines.

Tim Wright, Editor, Contract Pharma 02.25.21

Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology

CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing

Will leverage quantum machine learning for novel cancer treatment biomarker discovery.

Tim Wright, Editor, Contract Pharma 02.25.21

Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments

Glatt and Aprecia Enter 3D-Printing Collaboration

Aprecia's compression-free 3DP manufacturing platform expands Glatt capabilities in innovative particle design.

Tim Wright, Editor, Contract Pharma 02.23.21

Catalent Acquires Delphi Genetics

Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.

Tim Wright, Editor, Contract Pharma 02.23.21

Breaking News | Collaborations & Alliances

NovalGen and Halix Enter Strategic Partnership

Halix will provide manufacturing of clinical supply of NovalGen’s therapies.

Charles Sternberg, Assistant Editor 02.22.21

RedHill and Cosmo Strengthen Manufacturing Agreements

Secures manufacturing capacity of Movantik for opioid-induced constipation and RHB-204, currently in a Phase 3 study for pulmonary NTM disease.

Tim Wright, Editor, Contract Pharma 02.19.21

Breaking News | Collaborations & Alliances | Drug Development

Lilly, Rigel Enter Exclusive CNS Development Collaboration

Lilly will pay $125 million upfront and up to $835 million in potential milestones for Rigel's lead RIPK1 inhibitor, R552.

Kristin Brooks 02.18.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech To Supply 200M More Vax Doses to EU

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021.

Charles Sternberg, Assistant Editor 02.17.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Novavax, SK Bioscience Expand Vax Pact

The existing partnership for manufacture of NVX-CoV2373 has been expanded to increase production capacity and supply vaccines to the Korean Government.

Charles Sternberg, Assistant Editor 02.17.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Biomunex, Onward Ink Strategic Antibody Development Pact

Exclusive worldwide license and development agreement will leverage Biomunex' next gen bi- and multi-specific antibody platform in hematological malignancies.

Kristin Brooks 02.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine

U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people.

Tim Wright, Editor, Contract Pharma 02.12.21

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

For EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody.

Tim Wright, Editor, Contract Pharma 02.12.21

Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development

Molecular Templates, BMS Enter Strategic Research Pact

Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.

Kristin Brooks 02.11.21

Breaking News | Collaborations & Alliances | Industry News | Parenterals

LipoMedix, ForDoz Enter Manufacturing Agreement

Lead compound Promitil will be manufactured in the U.S. by ForDoz.

Tim Wright, Editor, Contract Pharma 02.10.21

FOLLOW:

Search Results for 'collaboration'

April 2021

follow us